PAOG To Expand Revenue Base Introducing New CBD Nutraceuticals Targeting $3.8 Billion Market

Sandusky, Ohio–(Newsfile Corp. – February 4, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today revealed plans to expand its nutraceutical product reach. The company plans to produce nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from…
Read more on “Newsfile”